Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shandong Weigao Orthopaedic Device Co's earnings before interest and taxes (EBIT) for the
three
months ended in Mar. 2026 was ¥53 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥309 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Shandong Weigao Orthopaedic Device Co's annualizedROC % for the quarter that ended in Mar. 2026 was 5.73%.
Shandong Weigao Orthopaedic Device Co's annualizedROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 9.78%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Shandong Weigao Orthopaedic Device Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 4.44%.
Shandong Weigao Orthopaedic Device Co (SHSE:688161) EBIT Explanation
1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Shandong Weigao Orthopaedic Device Co's annualizedROC % for the quarter that ended in Mar. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Orthopaedic Device Co EBIT Related Terms
Shandong Weigao Orthopaedic Device Co EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Shandong Weigao Orthopaedic Device Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Weigao Orthopaedic Device Co EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Orthopaedic Device Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Shandong Weigao Orthopaedic Device Co's EV-to-EBIT falls into.
Shandong Weigao Orthopaedic Device Co EBIT Calculation
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥309 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Orthopaedic Device Co (SHSE:688161) has a EBIT of ¥309 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Shandong Weigao Orthopaedic Device Co.
Is Shandong Weigao Orthopaedic Device Co's EBIT too high?
Shandong Weigao Orthopaedic Device Co's current EBIT is ¥309 Mil. Overall, Shandong Weigao Orthopaedic Device Co has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Orthopaedic Device Co's EBIT compare to ABT and SYK?
Shandong Weigao Orthopaedic Device Co's EBIT of ¥309 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Shandong Weigao Orthopaedic Device Co. Shandong Weigao Orthopaedic Device Co's current EBIT is ¥309 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Orthopaedic Device Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Orthopaedic Device Co (SHSE:688161) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥32.43, compared to a current price of ¥21.76 — trading 32.9% below its estimated fair value. The current EBIT is ¥309 Mil. Shandong Weigao Orthopaedic Device Co's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Shandong Weigao Orthopaedic Device Co (SHSE:688161), the current EBIT is ¥309 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Weigao Orthopaedic Device Co (SHSE:688161) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Weigao Orthopaedic Device Co stock appears to be undervalued.
The current stock price of ¥21.76 is trading 32.9% below its estimated GF Value™ of ¥32.43.
GuruFocus considers Shandong Weigao Orthopaedic Device Co to be Significantly Undervalued.
Key valuation signals for SHSE:688161:
EBIT: ¥309 Mil
GF Value™: ¥32.43 vs. price of ¥21.76 (32.9% below fair value)
No single metric tells the full story. See the SHSE:688161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Weigao Orthopaedic Device Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688161 has been successfully added to your 
